Cleared Traditional

K230275 - i-STAT CG8+ cartridge with the i-STAT 1...

K230275 is an FDA 510(k) clearance for i-STAT CG8+ cartridge with the i-STAT 1..., manufactured by Abbott Point of Care, Inc.. The device is a Class 2 Chemistry device with product code JGS cleared through the Traditional 510(k) pathway after a 268-day FDA review.

K230275 · Abbott Point of Care, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2023
Decision
268d
Days
Class 2
Risk

K230275 is an FDA 510(k) clearance for the i-STAT CG8+ cartridge with the i-STAT 1 System. Classified as Electrode, Ion Specific, Sodium (product code JGS), Class II - Special Controls.

Submitted by Abbott Point of Care, Inc. (Princton, US). The FDA issued a Cleared decision on October 27, 2023 after a review of 268 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1665 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Abbott Point of Care, Inc. devices

FDA 510(k) Submission Details - K230275

510(k) Number K230275 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 01, 2023
Decision Date October 27, 2023
Days to Decision 268 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
180d slower than avg
Panel avg: 88d · This submission: 268d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JGS Device Classification - Class 2, Special Controls

Product Code JGS Electrode, Ion Specific, Sodium
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1665
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JGS Electrode, Ion Specific, Sodium

All 122
Devices cleared under the same product code (JGS) and FDA review panel - the closest regulatory comparables to K230275.
ABL90 FLEX PLUS System
K252475 · Radiometer Medicals Aps · May 2026
A-LYTE® Integrated Multisensor (IMT Na K Cl)
K222438 · Siemens Healthcare Diagnostics, Inc. · Jul 2023
ISE Reagents, Glucose, CRP Latex, DxC 500 AU Clinical Chemistry Analyzer
K220977 · Beckman Coulter Laboratory Systems (Suzhou) Co., Ltd. · Jul 2023
GLP systems Track
K213486 · Abbott Laboratories · Mar 2022
Stat Profile Prime Plus Analyzer System
K200403 · Nova Biomedical Corporation · Apr 2020
i-STAT CHEM8+ cartridge with the i-STAT 1 System
K183688 · Abbott Point of Care, Inc. · Feb 2020